Cat allergy vaccine update: Circassia Achieves Successful Phase II Clinical Results With ToleroMune® Anti-Allergy Technology

According to Circassia, Ltd., which is in the process of human clinical trials of their upcoming cat allergy vaccine, ToleroMune®, they have achieved promising results from their phase II clinical study. As their recent media release states: Circassia Ltd, a specialty biopharmaceutical company focused on controlling immune system responses, today announced positive results from a phase…

Exciting news! Cat allergy vaccine trials now recruiting!

I’ve been following the development of the cat allergy vaccine since it was first announced a few years ago. The clinical trials are now in the home stretch, and if approved, the vaccine may be available as early as 2015. This is wonderful news for cat lovers with allergies. Whether the cat allergy vaccine will…